- Home
- PRSO vs HOTH Comparison
PRSO vs HOTH Comparison
Compare PRSO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- HOTH
- Stock Information
- Founded
- PRSO 2008
- HOTH 2017
- Country
- PRSO United States
- HOTH United States
- Employees
- PRSO N/A
- HOTH N/A
- Industry
- PRSO Semiconductors
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- HOTH Health Care
- Exchange
- PRSO Nasdaq
- HOTH Nasdaq
- Market Cap
- PRSO 18.4M
- HOTH 18.0M
- IPO Year
- PRSO 2001
- HOTH 2019
- Fundamental
- Price
- PRSO $1.44
- HOTH $1.38
- Analyst Decision
- PRSO Strong Buy
- HOTH Strong Buy
- Analyst Count
- PRSO 1
- HOTH 2
- Target Price
- PRSO $3.00
- HOTH $4.50
- AVG Volume (30 Days)
- PRSO 2.4M
- HOTH 994.3K
- Earning Date
- PRSO 11-10-2025
- HOTH 11-11-2025
- Dividend Yield
- PRSO N/A
- HOTH N/A
- EPS Growth
- PRSO N/A
- HOTH N/A
- EPS
- PRSO N/A
- HOTH N/A
- Revenue
- PRSO $13,608,000.00
- HOTH N/A
- Revenue This Year
- PRSO N/A
- HOTH N/A
- Revenue Next Year
- PRSO $34.49
- HOTH N/A
- P/E Ratio
- PRSO N/A
- HOTH N/A
- Revenue Growth
- PRSO 1.80
- HOTH N/A
- 52 Week Low
- PRSO $0.52
- HOTH $0.66
- 52 Week High
- PRSO $2.37
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- PRSO 49.06
- HOTH 40.64
- Support Level
- PRSO $1.38
- HOTH $1.34
- Resistance Level
- PRSO $1.57
- HOTH $1.52
- Average True Range (ATR)
- PRSO 0.21
- HOTH 0.09
- MACD
- PRSO -0.05
- HOTH -0.01
- Stochastic Oscillator
- PRSO 5.61
- HOTH 22.77
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).